|
|
| | H-ARG-PHE-TYR-VAL-VAL-MET-OH Basic information |
| Product Name: | H-ARG-PHE-TYR-VAL-VAL-MET-OH | | Synonyms: | ARG-PHE-TYR-VAL-VAL-MET;H-ARG-PHE-TYR-VAL-VAL-MET-OH;THROMBOSPONDIN-1 (1016-1021) (HUMAN, BOVINE, MOUSE);TS1 (1016-1021) (HUMAN, BOVINE, MOUSE);L-Methionine, L-arginyl-L-phenylalanyl-L-tyrosyl-L-valyl-L-valyl-;L-Arginyl-L-phenylalanyl-L-tyrosyl-L-valyl-L-valyl-L-methionine;Thrombospondin-1 (1016-1021) (human, bovine, mouse) H-Arg-Phe-Tyr-Val-Val-Met-OH;Thrombospondin-1 (1016-1021) | | CAS: | 149234-06-0 | | MF: | C39H59N9O8S | | MW: | 814.01 | | EINECS: | | | Product Categories: | | | Mol File: | 149234-06-0.mol |  |
| | H-ARG-PHE-TYR-VAL-VAL-MET-OH Chemical Properties |
| density | 1.33±0.1 g/cm3(Predicted) | | storage temp. | -15°C | | pka | 3.23±0.10(Predicted) |
| | H-ARG-PHE-TYR-VAL-VAL-MET-OH Usage And Synthesis |
| Uses | Thrombospondin-1 (1016-1021) (human, bovine, mouse), a Thrombospondin-1-derived peptide, is a truncated peptide devoid of CD47-binding activity[1]. | | References | [1] Sylvie Cointe, et al. Thrombospondin-1-Derived Peptide RFYVVMWK Improves the Adhesive Phenotype of CD34+ Cells From Atherosclerotic Patients With Type 2 Diabetes. Cell Transplant. 2017 Feb 16;26(2):327-337. DOI:10.3727/096368916X693329 |
| | H-ARG-PHE-TYR-VAL-VAL-MET-OH Preparation Products And Raw materials |
|